NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Fisker Inc. (“Fisker” or the “Company”) (NYSE: FSR). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
The investigation concerns whether Fisker and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On November 8, 2023, Fisker announced that it was delaying the release of its third quarter 2023 financial results, which were due before markets opened that day, until after markets close on November 13, 2023. Fisker blamed the delay on the unexplained departure of its now-former Chief Accounting Officer on October 27, 2023 and the appointment of a replacement effective November 6, 2023.
On this news, Fisker’s Class A common stock price fell $0.38 per share, or 8.7%, to close at $3.99 per share on November 8, 2023.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980
- EU’s Champions League: Sweden, Czech Republic, and Greece Score Big Against Smoking - July 3, 2025
- BITF DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bitfarms Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 8 Deadline in Securities Class Action – BITF - July 2, 2025
- Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak - July 2, 2025
